Log In
BCIQ
Print this Print this
 

BenzEFoam, benzoyl peroxide foam

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionBenzoyl peroxide 5.3% emollient foam
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat body acne
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$500.0M

$475.0M

$25.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/08/2014

$500.0M

$475.0M

$25.0M

Get a free BioCentury trial today